TECENTRIQ ATEZOLIZUMAB 60 MG / ML FAM CAJ/1

Name: TECENTRIQ

Category: ONCOLOGY

Active ingredient: ATEZOLIZUMAB

Description: Immunotherapy (anti-PD-L1 monoclonal antibody). Mechanism: Inhibits PD-L1, activating the immune response against tumor cells. Use: Lung, bladder, breast cancer, among others.

Weight: 1200 MG

Presentation: 1 BOTTLE 20 ML

Recipe: YES

Cold Network: YES

Temperature: REFRIGERATED: 2°-8° C

Health Registration: 225M2018 SSA

Important Notice

The information provided by Farmacias Hernandez Santé is for informational and educational purposes only.

Remember:

• This content is not a substitute for professional medical diagnosis, treatment, or prescription.
• Always consult your specialist before starting, modifying, or discontinuing any treatment.
• The proper use of medications should be supervised by a health professional.

Your well-being is our priority.